Clinical Trial Details
Return to Clinical Trials Home| Actively Enrolling | Yes |
| Primary Investigator | Dunn, David |
| Title | A Double Blind Placebo Controlled Study of Atomoxetine Hydrochloride for the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents with ADHD and Comorbid Dyslexia. |
| Date Published | May 27th, 2010 |
| Contact Name | Alisha Baker |
| Contact Phone | 317-278-3472 |
| Compensation | Yes |
| Disease | ADHD & Dyslexia |
| Healthy Volunteers | No |
| Inclusion / Exclusion | Participants must be aged 10
through 16 years, diagnosed with ADHD and/or Dyslexia. A smaller number of participants are needed with ADHD alone or with Dyslexia alone. Participants must be able to comply with study medication and having blood drawn.... More |